Vestmark Advisory Solutions’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-7,142
| Closed | -$1.12M | – | 759 |
|
2020
Q4 | $1.12M | Buy |
7,142
+405
| +6% | +$63.3K | 0.13% | 223 |
|
2020
Q3 | $771K | Buy |
6,737
+624
| +10% | +$71.4K | 0.1% | 256 |
|
2020
Q2 | $686K | Buy |
6,113
+733
| +14% | +$82.3K | 0.11% | 250 |
|
2020
Q1 | $483K | Buy |
+5,380
| New | +$483K | 0.09% | 275 |
|
2019
Q4 | – | Sell |
-5,424
| Closed | -$531K | – | 544 |
|
2019
Q3 | $531K | Buy |
5,424
+2,018
| +59% | +$198K | 0.09% | 288 |
|
2019
Q2 | $446K | Buy |
3,406
+164
| +5% | +$21.5K | 0.08% | 305 |
|
2019
Q1 | $438K | Buy |
+3,242
| New | +$438K | 0.08% | 307 |
|